Ming Hsieh, BSEE ’83, MSEE ’84, is a USC Trustee and alumnus. Hsieh currently serves as Chairman, CEO, and Co-founder of Fulgent Therapeutics, which develops targeted nano-delivery platform technologies and innovative biological drugs to combat cancers. Prior to Fulgent Therapeutics, Hsieh was Chairman, CEO, and Co-founder of Cogent, Inc. Under his leadership, Cogent became the worldwide leader in providing law enforcement, military, and commercial enterprises and other government agencies with large-scale, reliable, accurate, and real-time biometrics identification services. In 2006, Hsieh endowed the USC Ming Hsieh Department of Electrical and Computer Engineering, the USC Viterbi School’s largest and oldest department. Elected 2015.